Download PDF
Semin Respir Crit Care Med 2020; 41(01): 013-030
DOI: 10.1055/s-0039-1698429
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Current Concepts in the Epidemiology, Diagnosis, and Management of Histoplasmosis Syndromes

Marwan M. Azar
1   Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut
,
James L. Loyd
2   Vanderbilt University School of Medicine, Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Nashville, Tennessee
,
Ryan F. Relich
3   Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana
,
L. Joseph Wheat
4   MiraVista Diagnostics, Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Indianapolis, Indiana
,
Chadi A. Hage
3   Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana
› Author Affiliations
Further Information

Publication History

Publication Date:
30 January 2020 (online)

    Permissions and Reprints

Abstract

Histoplasmosis is a global disease endemic to regions of all six inhabited continents. The areas of highest endemicity lie within the Mississippi and Ohio River Valleys of North America and parts of Central and South America. As a result of climate change and anthropogenic land utilization, the conditions suitable for Histoplasma capsulatum are changing, leading to a corresponding change in epidemiology. The clinical manifestations of histoplasmosis are protean, variably resembling other common conditions such as community-acquired pneumonia, tuberculosis, sarcoidosis, Crohn's disease, or malignancy. Making a successful diagnosis is contingent on a thorough understanding of epidemiology, common clinical presentations, and best testing practices for histoplasmosis. While most subclinical or self-limited diseases do not require treatment in immunocompetent patients, all immunocompromised patients and those with progressive disseminated disease or chronic pulmonary disease should be treated. Liposomal amphotericin B is the preferred agent for severe or disseminated disease, while itraconazole is adequate for milder cases and “step-down” therapy following response to amphotericin B. In this review, we discuss the current evidence-based approaches to the epidemiology, diagnosis, and management of histoplasmosis.

Keywords

histoplasmosis - pneumonia - disseminated - epidemiology - diagnosis - antigen - antibody - treatment
 

  • References

  • 1 Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969; 99 (4, Suppl): 1-132
    PubMedGoogle Scholar
  • 2 Manos NE, Ferebee SH, Kerschbaum WF. Geographic variation in the prevalence of histoplasmin sensitivity. Dis Chest 1956; 29 (06) 649-668
    CrossrefPubMedGoogle Scholar
  • 3 Baddley JW, Winthrop KL, Patkar NM. , et al. Geographic distribution of endemic fungal infections among older persons, United States. Emerg Infect Dis 2011; 17 (09) 1664-1669
    CrossrefPubMedGoogle Scholar
  • 4 Benedict K, Mody RK. Epidemiology of histoplasmosis outbreaks, United States, 1938–2013. Emerg Infect Dis 2016; 22 (03) 370-378
    PubMedGoogle Scholar
  • 5 Nett RJ, Skillman D, Riek L. , et al. Histoplasmosis in Idaho and Montana, USA, 2012–2013. Emerg Infect Dis 2015; 21 (06) 1071-1072
    CrossrefPubMedGoogle Scholar
  • 6 Azar MM, Zhang X, Assi R, Hage C, Wheat LJ, Malinis MF. Clinical and epidemiological characterization of histoplasmosis cases in a nonendemic area, Connecticut, United States. Med Mycol 2018; 56 (07) 896-899
    CrossrefPubMedGoogle Scholar
  • 7 Gandhi V, Ulyanovskiy P, Epelbaum O. Update on the spectrum of histoplasmosis among hispanic patients presenting to a New York City municipal hospital: a contemporary case series. Respir Med Case Rep 2015; 16: 60-64
    PubMedGoogle Scholar
  • 8 Anderson AM, Mehta AK, Wang YF, Jing Qian, Easley K, Nguyen ML. HIV-associated histoplasmosis in a nonendemic area of the United States during the HAART era: role of migration from endemic areas and lack of antiretroviral therapy. J Int Assoc Physicians AIDS Care (Chic) 2010; 9 (05) 296-300
    CrossrefPubMedGoogle Scholar
  • 9 Maiga AW, Deppen S, Scaffidi BK. , et al. Mapping Histoplasma capsulatum exposure, United States. Emerg Infect Dis 2018; 24 (10) 1835-1839
    CrossrefPubMedGoogle Scholar
  • 10 Benedict K, Derado G, Mody RK. Histoplasmosis-associated hospitalizations in the United States, 2001–2012. Open Forum Infect Dis 2016; 3 (01) ofv219
    CrossrefPubMedGoogle Scholar
  • 11 Colombo AL, Tobón A, Restrepo A, Queiroz-Telles F, Nucci M. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol 2011; 49 (08) 785-798
    PubMedGoogle Scholar
  • 12 Nucci M, Queiroz-Telles F, Tobón AM, Restrepo A, Colombo AL. Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis 2010; 51 (05) 561-570
    CrossrefPubMedGoogle Scholar
  • 13 Damasceno LS, Ramos Jr AN, Alencar CH. , et al. Disseminated histoplasmosis in HIV-infected patients: determinants of relapse and mortality in a north-eastern area of Brazil. Mycoses 2014; 57 (07) 406-413
    CrossrefPubMedGoogle Scholar
  • 14 Falci DR, Monteiro AA, Braz Caurio CF. , et al. Histoplasmosis, an underdiagnosed disease affecting people living with HIV/AIDS in Brazil: results of a multicenter prospective cohort study using both classical mycology tests and Histoplasma urine antigen detection. Open Forum Infect Dis 2019; 6 (04) ofz073
    PubMedGoogle Scholar
  • 15 Nacher M, Adenis A, Mc Donald S. , et al. Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage. PLoS Negl Trop Dis 2013; 7 (11) e2319
    CrossrefPubMedGoogle Scholar
  • 16 Pietrobon D, Negro-Marquínez L, Kilstein J, Galíndez J, Greca A, Battagliotti C. Disseminated histoplasmosis and AIDS in an Argentine hospital: clinical manifestations, diagnosis and treatment [in Spanish]. Enferm Infecc Microbiol Clin 2004; 22 (03) 156-159
    CrossrefPubMedGoogle Scholar
  • 17 Tobón AM, Agudelo CA, Rosero DS. , et al. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am J Trop Med Hyg 2005; 73 (03) 576-582
    PubMedGoogle Scholar
  • 18 Mata-Essayag S, Colella MT, Roselló A. , et al. Histoplasmosis: a study of 158 cases in Venezuela, 2000–2005. Medicine (Baltimore) 2008; 87 (04) 193-202
    PubMedGoogle Scholar
  • 19 Segura L, Rojas M, Pelaez N. , et al. Disseminated histoplasmosis and human immunodeficiency virus type 1 infection: risk factors in Guatemala. Clin Infect Dis 1997; 25 (02) 343-344
    CrossrefPubMedGoogle Scholar
  • 20 Gutierrez ME, Canton A, Sosa N, Puga E, Talavera L. Disseminated histoplasmosis in patients with AIDS in Panama: a review of 104 cases. Clin Infect Dis 2005; 40 (08) 1199-1202
    CrossrefPubMedGoogle Scholar
  • 21 Arango M, Castañeda E, Agudelo CI. , et al; Colombian Histoplasmosis Study Group. Histoplasmosis: results of the Colombian national survey, 1992–2008. Biomedica 2011; 31 (03) 344-356
    PubMedGoogle Scholar
  • 22 Peigne V, Dromer F, Elie C, Lidove O, Lortholary O. ; French Mycosis Study Group. Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras. Am J Trop Med Hyg 2011; 85 (05) 934-941
    PubMedGoogle Scholar
  • 23 Antinori S, Magni C, Nebuloni M. , et al. Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore) 2006; 85 (01) 22-36
    PubMedGoogle Scholar
  • 24 Farina C, Rizzi M, Ricci L, Gabbi E, Caligaris S, Goglio A. Imported and autochthonous histoplasmosis in Italy: new cases and old problems. Rev Iberoam Micol 2005; 22 (03) 169-171
    CrossrefPubMedGoogle Scholar
  • 25 Hay RJ, White HS, Fields PE, Quamina DB, Dan M, Jones TR. Histoplasmosis in the eastern Caribbean: a preliminary survey of the incidence of the infection. J Trop Med Hyg 1981; 84 (01) 9-12
    PubMedGoogle Scholar
  • 26 Wen FQ, Sun YD, Watanabe K, Yoshida M, Wu JN, Baum GL. Prevalence of histoplasmin sensitivity in healthy adults and tuberculosis patients in southwest China. J Med Vet Mycol 1996; 34 (03) 171-174
    CrossrefPubMedGoogle Scholar
  • 27 Pan B, Chen M, Pan W, Liao W. Histoplasmosis: a new endemic fungal infection in China? Review and analysis of cases. Mycoses 2013; 56 (03) 212-221
    CrossrefPubMedGoogle Scholar
  • 28 Norkaew T, Ohno H, Sriburee P. , et al. Detection of environmental sources of Histoplasma capsulatum in Chiang Mai, Thailand, by nested PCR. Mycopathologia 2013; 176 (5–6): 395-402
    CrossrefPubMedGoogle Scholar
  • 29 Rangwala F, Putcharoen O, Bowonwatanuwong C. , et al. Histoplasmosis and penicilliosis among HIV-infected Thai patients: a retrospective review. Southeast Asian J Trop Med Public Health 2012; 43 (02) 436-441
    PubMedGoogle Scholar
  • 30 Bulmer AC, Bulmer GS. Incidence of histoplasmin hypersensitivity in the Philippines. Mycopathologia 2001; 149 (02) 69-71
    CrossrefPubMedGoogle Scholar
  • 31 Azar MM, Malinis MF. Disseminated histoplasmosis with skin lesions and osteomyelitis in a patient from the Philippines. Am J Trop Med Hyg 2016; 95 (01) 70-74
    PubMedGoogle Scholar
  • 32 Randhawa HS, Gugnani HC. Occurrence of histoplasmosis in the Indian sub-continent: an overview and update. J Med Res Prac 2018; 7: 71-83
    PubMedGoogle Scholar
  • 33 Pakasa N, Biber A, Nsiangana S. , et al. African histoplasmosis in HIV-negative patients, Kimpese, Democratic Republic of the Congo. Emerg Infect Dis 2018; 24 (11) 2068-2070
    CrossrefPubMedGoogle Scholar
  • 34 Lofgren SM, Kirsch EJ, Maro VP. , et al. Histoplasmosis among hospitalized febrile patients in northern Tanzania. Trans R Soc Trop Med Hyg 2012; 106 (08) 504-507
    CrossrefPubMedGoogle Scholar
  • 35 Gumbo T, Just-Nübling G, Robertson V, Latif AS, Borok MZ, Hohle R. Clinicopathological features of cutaneous histoplasmosis in human immunodeficiency virus-infected patients in Zimbabwe. Trans R Soc Trop Med Hyg 2001; 95 (06) 635-636
    CrossrefPubMedGoogle Scholar
  • 36 Ramdial KP, Mosam A, Dlova NC, Satar BN, Aboobaker J, Singh SM. ; P KR. Disseminated cutaneous histoplasmosis in patients infected with human immunodeficiency virus. J Cutan Pathol 2002; 29 (04) 215-225
    CrossrefPubMedGoogle Scholar
  • 37 Gugnani HC, Muotoe-Okafor F. African histoplasmosis: a review. Rev Iberoam Micol 1997; 14 (04) 155-159
    PubMedGoogle Scholar
  • 38 Staffolani S, Buonfrate D, Angheben A. , et al. Acute histoplasmosis in immunocompetent travelers: a systematic review of literature. BMC Infect Dis 2018; 18 (01) 673
    CrossrefPubMedGoogle Scholar
  • 39 Benedict K, Beer KD, Jackson BR. Histoplasmosis-related healthcare use, diagnosis, and treatment in a commercially insured population, United States. Clin Infect Dis 2019 (e-pub ahead of print). Doi: 10.1093/cid/ciz324
    PubMedGoogle Scholar
  • 40 Sethi J, Gupta KL, Mohanty T, Gupta S, Ahluwalia J, Kohli HS. Fever of unknown origin in a renal transplant recipient: lactate dehydrogenase as an important clue to diagnosis. Exp Clin Transplant 2019 (e-pub ahead of print). Doi: 10.6002/ect.2018.0380
    PubMedGoogle Scholar
  • 41 Spec A, Barrios CR, Ahmad U, Proia LA. AST to ALT ratio is elevated in disseminated histoplasmosis as compared to localized pulmonary disease and other endemic mycoses. Med Mycol 2017; 55 (05) 541-545
    PubMedGoogle Scholar
  • 42 Connolly PA, Durkin MM, Lemonte AM, Hackett EJ, Wheat LJ. Detection of histoplasma antigen by a quantitative enzyme immunoassay. Clin Vaccine Immunol 2007; 14 (12) 1587-1591
    CrossrefPubMedGoogle Scholar
  • 43 Azar MM, Hage CA. Laboratory diagnostics for histoplasmosis. J Clin Microbiol 2017; 55 (06) 1612-1620
    CrossrefPubMedGoogle Scholar
  • 44 Myint T, Anderson AM, Sanchez A. , et al. Histoplasmosis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): multicenter study of outcomes and factors associated with relapse. Medicine (Baltimore) 2014; 93 (01) 11-18
    PubMedGoogle Scholar
  • 45 Hage CA, Bowyer S, Tarvin SE, Helper D, Kleiman MB, Wheat LJ. Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis 2010; 50 (01) 85-92
    CrossrefPubMedGoogle Scholar
  • 46 Assi M, Martin S, Wheat LJ. , et al. Histoplasmosis after solid organ transplant. Clin Infect Dis 2013; 57 (11) 1542-1549
    CrossrefPubMedGoogle Scholar
  • 47 Assi MA, Sandid MS, Baddour LM, Roberts GD, Walker RC. Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore) 2007; 86 (03) 162-169
    PubMedGoogle Scholar
  • 48 Hage CA, Ribes JA, Wengenack NL. , et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis 2011; 53 (05) 448-454
    CrossrefPubMedGoogle Scholar
  • 49 Swartzentruber S, Rhodes L, Kurkjian K. , et al. Diagnosis of acute pulmonary histoplasmosis by antigen detection. Clin Infect Dis 2009; 49 (12) 1878-1882
    CrossrefPubMedGoogle Scholar
  • 50 Wheat LJ, Connolly-Stringfield P, Williams B. , et al. Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid. Am Rev Respir Dis 1992; 145 (06) 1421-1424
    CrossrefPubMedGoogle Scholar
  • 51 Hage CA, Davis TE, Fuller D. , et al. Diagnosis of histoplasmosis by antigen detection in BAL fluid. Chest 2010; 137 (03) 623-628
    CrossrefPubMedGoogle Scholar
  • 52 Wheat J, Myint T, Guo Y. , et al. Central nervous system histoplasmosis: multicenter retrospective study on clinical features, diagnostic approach and outcome of treatment. Medicine (Baltimore) 2018; 97 (13) e0245
    PubMedGoogle Scholar
  • 53 Hage CA, Kirsch EJ, Stump TE. , et al. Histoplasma antigen clearance during treatment of histoplasmosis in patients with AIDS determined by a quantitative antigen enzyme immunoassay. Clin Vaccine Immunol 2011; 18 (04) 661-666
    CrossrefPubMedGoogle Scholar
  • 54 Wheat LJ, Connolly P, Durkin M. , et al. False-positive Histoplasma antigenemia caused by antithymocyte globulin antibodies. Transpl Infect Dis 2004; 6 (01) 23-27
    CrossrefPubMedGoogle Scholar
  • 55 Kaur A, Eberlein M, Klesney-Tait J, Durkin MM, Wheat LJ, Gajurel K. Rabbit antithymocyte globulin causes Blastomyces and Histoplasma antigenemia. Open Forum Infect Dis 2019; 6 (05) ofz165
    CrossrefPubMedGoogle Scholar
  • 56 Theel ES, Ramanan P. Clinical significance of low-positive histoplasma urine antigen results. J Clin Microbiol 2014; 52 (09) 3444-3446
    CrossrefPubMedGoogle Scholar
  • 57 Wheat J, French ML, Kohler RB. , et al. The diagnostic laboratory tests for histoplasmosis: analysis of experience in a large urban outbreak. Ann Intern Med 1982; 97 (05) 680-685
    PubMedGoogle Scholar
  • 58 CSTE. Standardized surveillance case definition for histoplasmosis. 2016 . Available at: https://cdn.ymaws.com/www.cste.org/resource/resmgr/2016PS/16_ID_02.pdf . Accessed September 16, 2019
    PubMedGoogle Scholar
  • 59 Richer SM, Smedema ML, Durkin MM. , et al. Improved diagnosis of acute pulmonary histoplasmosis by combining antigen and antibody detection. Clin Infect Dis 2016; 62 (07) 896-902
    CrossrefPubMedGoogle Scholar
  • 60 Simon S, Veron V, Boukhari R, Blanchet D, Aznar C. Detection of Histoplasma capsulatum DNA in human samples by real-time polymerase chain reaction. Diagn Microbiol Infect Dis 2010; 66 (03) 268-273
    CrossrefPubMedGoogle Scholar
  • 61 Stempak LM, Vogel SA, Richter SS, Wyllie R, Procop GW. Routine broad-range fungal polymerase chain reaction with DNA sequencing in patients with suspected mycoses does not add value and is not cost-effective. Arch Pathol Lab Med 2019; 143 (05) 634-638
    CrossrefPubMedGoogle Scholar
  • 62 Accuprobe. [package insert]. GenProbe Inc., San Diego, CA; 2011 . Available at: http://www.hologic.ca/sites/default/files/package%20inserts/102962RevK.pdf . Accessed Feb 20 2017
    PubMed
  • 63 Wilson MR, O'Donovan BD, Gelfand JM. , et al. Chronic meningitis investigated via metagenomic next-generation sequencing. JAMA Neurol 2018; 75 (08) 947-955
    CrossrefPubMedGoogle Scholar
  • 64 Rubio-Carrasquilla M, Santa CD, Rendón JP, Botero-Garcés J, Moreno E, Cano LE. An interferon gamma release assay specific for Histoplasma capsulatum to detect asymptomatic infected individuals: a proof of concept study. Med Mycol 2018 (e-pub ahead of print). Doi: 10.1093/mmy/myy131
    PubMedGoogle Scholar
  • 65 Valero C, Buitrago MJ, Gago S, Quiles-Melero I, García-Rodríguez J. A matrix-assisted laser desorption/ionization time of flight mass spectrometry reference database for the identification of Histoplasma capsulatum. Med Mycol 2018; 56 (03) 307-314
    CrossrefPubMedGoogle Scholar
  • 66 Reynolds III RJ, Penn RL, Grafton WD, George RB. Tissue morphology of Histoplasma capsulatum in acute histoplasmosis. Am Rev Respir Dis 1984; 130 (02) 317-320
    CrossrefPubMedGoogle Scholar
  • 67 Sollod N. Acute fulminating disseminated histoplasmosis. Report of an unusual outbreak. J S C Med Assoc 1971; 67 (05) 231-234
    PubMedGoogle Scholar
  • 68 Wheat LJ, Slama TG, Norton JA. , et al. Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak. Ann Intern Med 1982; 96 (02) 159-163
    PubMedGoogle Scholar
  • 69 Wynne JW, Olsen GN. Acute histoplasmosis presenting as the adult respiratory distress syndrome. Chest 1974; 66 (02) 158-161
    CrossrefPubMedGoogle Scholar
  • 70 Johnson PC, Wheat LJ, Cloud GA. , et al; U.S. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 2002; 137 (02) 105-109
    PubMedGoogle Scholar
  • 71 Egressy KvL, Mohammed M, Ferguson JS. The use of endobronchial ultrasound in the diagnosis of subacute pulmonary histoplasmosis. Diagn Ther Endosc 2015; 2015: 6
    PubMedGoogle Scholar
  • 72 Wheat LJ, Wass J, Norton J, Kohler RB, French ML. Cavitary histoplasmosis occurring during two large urban outbreaks. Analysis of clinical, epidemiologic, roentgenographic, and laboratory features. Medicine (Baltimore) 1984; 63 (04) 201-209
    PubMedGoogle Scholar
  • 73 Goodwin Jr RA, Owens FT, Snell JD. , et al. Chronic pulmonary histoplasmosis. Medicine (Baltimore) 1976; 55 (06) 413-452
    PubMedGoogle Scholar
  • 74 Furcolow ML. Comparison of treated and untreated severe histoplasmosis: a communicable disease center cooperative mycoses study. JAMA 1963; 183: 823-829
    PubMedGoogle Scholar
  • 75 Baum GL, Larkin Jr JC, Sutliff WD. Follow-up of patients with chronic pulmonary histoplasmosis treated with amphotericin B. Chest 1970; 58 (06) 562-565
    CrossrefPubMedGoogle Scholar
  • 76 Mashburn JD, Dawson DF, Young JM. Pulmonary calcifications and histoplasmosis. Am Rev Respir Dis 1961; 84: 208-216
    PubMedGoogle Scholar
  • 77 Straub M, Schwarz J. The healed primary complex in histoplasmosis. Am J Clin Pathol 1955; 25 (07) 727-741
    CrossrefPubMedGoogle Scholar
  • 78 Mukhopadhyay S, Wilcox BE, Myers JL. , et al. Pulmonary necrotizing granulomas of unknown cause: clinical and pathologic analysis of 131 patients with completely resected nodules. Chest 2013; 144 (03) 813-824
    CrossrefPubMedGoogle Scholar
  • 79 Deppen S, Putnam Jr JB, Andrade G. , et al. Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease. Ann Thorac Surg 2011; 92 (02) 428-432 , discussion 433
    CrossrefPubMedGoogle Scholar
  • 80 Kadaria D, Archie DS, SultanAli I, Weiman DS, Freire AX, Zaman MK. Dual time point positron emission tomography/computed tomography scan in evaluation of intrathoracic lesions in an area endemic for histoplasmosis and with high prevalence of sarcoidosis. Am J Med Sci 2013; 346 (05) 358-362
    CrossrefPubMedGoogle Scholar
  • 81 Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med 2003; 348 (25) 2535-2542
    CrossrefPubMedGoogle Scholar
  • 82 Goodwin RA, Alcorn GL. Histoplasmosis with symptomatic lymphadenopathy. Chest 1980; 77 (02) 213-215
    CrossrefPubMedGoogle Scholar
  • 83 Goodwin RA, Loyd JE, Des Prez RM. Histoplasmosis in normal hosts. Medicine (Baltimore) 1981; 60 (04) 231-266
    PubMedGoogle Scholar
  • 84 Parish JM, Rosenow III EC. Mediastinal granuloma and mediastinal fibrosis. Semin Respir Crit Care Med 2002; 23 (02) 135-143
    Article in Thieme ConnectPubMedGoogle Scholar
  • 85 Goodwin RA, Nickell JA, Des Prez RM. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore) 1972; 51 (03) 227-246
    PubMedGoogle Scholar
  • 86 Johnson JA, Loyd JE, Wheat LJ, Netterville JL. A case series and review of histoplasmosis infection in the neck. Arch Otolaryngol Head Neck Surg 2010; 136 (09) 916-919
    CrossrefPubMedGoogle Scholar
  • 87 Savides TJ, Gress FG, Wheat LJ, Ikenberry S, Hawes RH. Dysphagia due to mediastinal granulomas: diagnosis with endoscopic ultrasonography. Gastroenterology 1995; 109 (02) 366-373
    CrossrefPubMedGoogle Scholar
  • 88 Rochester CL, Kradin RL. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-2000. A 47-year-old woman with multilobar pulmonary consolidation. N Engl J Med 2000; 343 (25) 1876-1884
    CrossrefPubMedGoogle Scholar
  • 89 Gula LJ, Malthaner RA, Quantz MA. Pyopneumopericardium caused by mediastinal granuloma. Ann Thorac Surg 2002; 74 (01) 241-243
    CrossrefPubMedGoogle Scholar
  • 90 Lentz RJ, Lambright ES, Maldonado F, Loyd J, Grogan EL, Rickman OB. Mediastinal granuloma superinfection following ultrasound-guided transbronchial needle aspiration: a case series. Am J Respir Crit Care Med 2016; 193: A3385
    PubMedGoogle Scholar
  • 91 Dines DE, Payne WS, Bernatz PE, Pairolero PC. Mediastinal granuloma and fibrosing mediastinitis. Chest 1979; 75 (03) 320-324
    CrossrefPubMedGoogle Scholar
  • 92 Loyd JE, Tillman BF, Atkinson JB, Des Prez RM. Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore) 1988; 67 (05) 295-310
    PubMedGoogle Scholar
  • 93 Peikert T, Colby TV, Midthun DE. , et al. Fibrosing mediastinitis: clinical presentation, therapeutic outcomes, and adaptive immune response. Medicine (Baltimore) 2011; 90 (06) 412-423
    PubMedGoogle Scholar
  • 94 Westerly BD, Johnson GB, Maldonado F, Utz JP, Specks U, Peikert T. Targeting B lymphocytes in progressive fibrosing mediastinitis. Am J Respir Crit Care Med 2014; 190 (09) 1069-1071
    CrossrefPubMedGoogle Scholar
  • 95 Albers EL, Pugh ME, Hill KD, Wang L, Loyd JE, Doyle TP. Percutaneous vascular stent implantation as treatment for central vascular obstruction due to fibrosing mediastinitis. Circulation 2011; 123 (13) 1391-1399
    CrossrefPubMedGoogle Scholar
  • 96 Ponamgi SP, DeSimone CV, Lenz CJ. , et al. Catheter-based intervention for pulmonary vein stenosis due to fibrosing mediastinitis: The Mayo Clinic experience. Int J Cardiol Heart Vasc 2015; 8: 103-107
    PubMedGoogle Scholar
  • 97 Recto MR, Bousamra M, Yeh Jr T. Late superior vena cava perforation and aortic laceration after stenting to treat superior vena cava syndrome secondary to fibrosing mediastinitis. J Invasive Cardiol 2002; 14 (10) 624-629
    PubMedGoogle Scholar
  • 98 Kern R, Peikert T, Edell E. , et al. Bronchoscopic management of airway compression due to fibrosing mediastinitis. Ann Am Thorac Soc 2017; 14 (08) 1353-1355
    CrossrefPubMedGoogle Scholar
  • 99 Kortsik C, Elmer A, Tamm I. Pleural effusion due to Histoplasma capsulatum and idiopathic CD4 lymphocytopenia. Respiration 2003; 70 (01) 118-122
    CrossrefPubMedGoogle Scholar
  • 100 Antachopoulos C, Walsh TJ, Roilides E. Fungal infections in primary immunodeficiencies. Eur J Pediatr 2007; 166 (11) 1099-1117
    CrossrefPubMedGoogle Scholar
  • 101 Alberti-Flor JJ, Granda A. Ileocecal histoplasmosis mimicking Crohn's disease in a patient with Job's syndrome. Digestion 1986; 33 (03) 176-180
    CrossrefPubMedGoogle Scholar
  • 102 Robinson WS, Arnold SR, Michael CF. , et al. Case report of a young child with disseminated histoplasmosis and review of hyper immunoglobulin e syndrome (HIES). Clin Mol Allergy 2011; 9: 14
    CrossrefPubMedGoogle Scholar
  • 103 Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis 2005; 41 (04) e38-e41
    PubMedGoogle Scholar
  • 104 Subbalaxmi MV, Umabala P, Paul R, Chandra N, Raju YS, Rudramurthy SM. A rare presentation of progressive disseminated histoplasmosis in an immunocompetent patient from a non-endemic region. Med Mycol Case Rep 2013; 2: 103-107
    CrossrefPubMedGoogle Scholar
  • 105 Grim SA, Proia L, Miller R. , et al. A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation. Transpl Infect Dis 2012; 14 (01) 17-23
    CrossrefPubMedGoogle Scholar
  • 106 Miller R, Assi M. ; AST Infectious Diseases Community of Practice. Endemic fungal infections in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; e13553
    PubMedGoogle Scholar
  • 107 Natarajan M, Swierzbinski MJ, Maxwell S. , et al. Pulmonary Histoplasma infection after allogeneic hematopoietic stem cell transplantation: case report and review of the literature. Open Forum Infect Dis 2017; 4 (02) ofx041
    CrossrefPubMedGoogle Scholar
  • 108 Conces Jr DJ, Stockberger SM, Tarver RD, Wheat LJ. Disseminated histoplasmosis in AIDS: findings on chest radiographs. AJR Am J Roentgenol 1993; 160 (01) 15-19
    CrossrefPubMedGoogle Scholar
  • 109 Riddell IV J, Kauffman CA, Smith JA. , et al. Histoplasma capsulatum endocarditis: multicenter case series with review of current diagnostic techniques and treatment. Medicine (Baltimore) 2014; 93 (05) 186-193
    PubMedGoogle Scholar
  • 110 Santiago AR, Hernández B, Rodríguez M, Romero H. A comparative study of blood culture conventional method vs. a modified lysis/centrifugation technique for the diagnosis of fungemias [in Spanish]. Rev Iberoam Micol 2004; 21 (04) 198-201
    PubMedGoogle Scholar
  • 111 Ramanan P, Vetter E, Milone AA, Patel R, Wengenack NL. Comparison of BACTEC MYCO/F lytic bottle to the wampole isolator for recovery of fungal and mycobacterial organisms. Open Forum Infect Dis 2016; 3: 1557
    CrossrefPubMedGoogle Scholar
  • 112 Vetter E, Torgerson C, Feuker A. , et al. Comparison of the BACTEC MYCO/F Lytic bottle to the isolator tube, BACTEC Plus Aerobic F/bottle, and BACTEC Anaerobic Lytic/10 bottle and comparison of the BACTEC Plus Aerobic F/bottle to the Isolator tube for recovery of bacteria, mycobacteria, and fungi from blood. J Clin Microbiol 2001; 39 (12) 4380-4386
    CrossrefPubMedGoogle Scholar
  • 113 Wheat J, MaWhinney S, Hafner R. , et al; National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. Am J Med 1997; 103 (03) 223-232
    CrossrefPubMedGoogle Scholar
  • 114 Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis 2005; 7 (3–4): 109-115
    CrossrefPubMedGoogle Scholar
  • 115 Restrepo A, Tobón A, Clark B. , et al. Salvage treatment of histoplasmosis with posaconazole. J Infect 2007; 54 (04) 319-327
    CrossrefPubMedGoogle Scholar
  • 116 Kraft WK, Chang PS, van Iersel ML, Waskin H, Krishna G, Kersemaekers WM. Posaconazole tablet pharmacokinetics: lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects. Antimicrob Agents Chemother 2014; 58 (07) 4020-4025
    CrossrefPubMedGoogle Scholar
  • 117 Maertens J, Cornely OA, Ullmann AJ. , et al. Phase 1B study of the pharmacokinetics and safety of posaconazole intravenous solution in patients at risk for invasive fungal disease. Antimicrob Agents Chemother 2014; 58 (07) 3610-3617
    CrossrefPubMedGoogle Scholar
  • 118 Duplessis CA, Tilley D, Bavaro M, Hale B, Holland SM. Two cases illustrating successful adjunctive interferon-γ immunotherapy in refractory disseminated coccidioidomycosis. J Infect 2011; 63 (03) 223-228
    CrossrefPubMedGoogle Scholar
  • 119 Vinh DC. Insights into human antifungal immunity from primary immunodeficiencies. Lancet Infect Dis 2011; 11 (10) 780-792
    CrossrefPubMedGoogle Scholar
  • 120 Ibrahim KY, Carvalho NB, Mimicos EV, Yeh-Li H, Sotto MN, França FO. Cutaneous and bone marrow histoplasmosis after 18 years of renal allograft transplant. Mycopathologia 2014; 178 (3–4): 273-278
    CrossrefPubMedGoogle Scholar
  • 121 Naeem F, Metzger ML, Arnold SR, Adderson EE. Distinguishing benign mediastinal masses from malignancy in a histoplasmosis-endemic region. J Pediatr 2015; 167 (02) 409-415
    CrossrefPubMedGoogle Scholar
  • 122 Cuellar-Rodriguez J, Avery RK, Lard M. , et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009; 49 (05) 710-716
    CrossrefPubMedGoogle Scholar
  • 123 Olson TC, Bongartz T, Crowson CS, Roberts GD, Orenstein R, Matteson EL. Histoplasmosis infection in patients with rheumatoid arthritis, 1998–2009. BMC Infect Dis 2011; 11: 145
    CrossrefPubMedGoogle Scholar
  • 124 Dotson JL, Crandall W, Mousa H. , et al. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series. Inflamm Bowel Dis 2011; 17 (01) 56-61
    CrossrefPubMedGoogle Scholar
  • 125 Vergidis P, Avery RK, Wheat LJ. , et al. Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis 2015; 61 (03) 409-417
    CrossrefPubMedGoogle Scholar